Inventor
WELLS JAMES A
US69 patents
⚠️ This page may combine multiple inventors who share the name “WELLS JAMES A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GENENTECH INC
38 patentsUS7169901B2Jan 30, 2007
Anti-VEGF antibodies
GENENTECH INC160 citations99
US7060269B1Jun 13, 2006
Anti-VEGF antibodies
GENENTECH INC342 citations99
US6884879B1Apr 26, 2005
Anti-VEGF antibodies
GENENTECH INC623 citations99
US6451561B1Sep 17, 2002
Growth hormone variants
GENENTECH INC96 citations99
US6022711AFeb 8, 2000
Human growth hormone variants having enhanced affinity for human growth hormone receptor at site 1
GENENTECH INC100 citations99
US6013478AJan 11, 2000
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC184 citations99
US5834598ANov 10, 1998
Human growth hormone variants
GENENTECH INC108 citations99
US5834250ANov 10, 1998
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC432 citations99
US5780279AJul 14, 1998
Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
GENENTECH INC198 citations99
US5580723ADec 3, 1996
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC212 citations99
US5534617AJul 9, 1996
Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
GENENTECH INC236 citations99
US7375193B2May 20, 2008
Anti-VEGF antibodies
GENENTECH INC62 citations98
US7365166B2Apr 29, 2008
Anti-VEGF antibodies
GENENTECH INC90 citations98
US7297334B2Nov 20, 2007
Anti-vegf antibodies
GENENTECH INC112 citations98
US6800740B1Oct 5, 2004
Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications
GENENTECH INC77 citations98
US6428954B1Aug 6, 2002
Method for identifying active domains and amino acid residues in polypeptides and hormone variants
GENENTECH INC94 citations98
US6057292AMay 2, 2000
Method for inhibiting growth hormone action
GENENTECH INC198 citations98
US6040136AMar 21, 2000
Enrichment method for variant proteins with altered binding properties
GENENTECH INC139 citations98
US6013763AJan 11, 2000
Peptide variants of protein A
GENENTECH INC146 citations98
US5849535ADec 15, 1998
Human growth hormone variants
GENENTECH INC346 citations98
US5821047AOct 13, 1998
Monovalent phage display
GENENTECH INC1,243 citations98
US5750373AMay 12, 1998
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
GENENTECH INC1,868 citations98
US5688666ANov 18, 1997
Growth hormone variants with altered binding properties
GENENTECH INC154 citations98
US6057428AMay 2, 2000
Variants of vascular endothelial cell growth factor
GENENTECH INC90 citations97
US6780613B1Aug 24, 2004
Growth hormone variants
GENENTECH INC49 citations96
US6429186B1Aug 6, 2002
Ligand antagonists for treatment of breast cancer
GENENTECH INC77 citations96
US6271198B1Aug 7, 2001
Constrained helical peptides and methods of making same
GENENTECH INC103 citations96
US6143523ANov 7, 2000
Human growth hormone variants
GENENTECH INC84 citations96
US5955346ASep 21, 1999
Variants of human prolactin and human placeatal lactogen
GENENTECH INC54 citations96
US5854026ADec 29, 1998
Human growth hormone variant having enhanced affinity for human growth hormone receptor at site 1
GENENTECH INC78 citations96
US5846765ADec 8, 1998
Identification of novel substrates
GENENTECH INC79 citations96
US6387638B1May 14, 2002
Heregulin variants
GENENTECH INC51 citations95
US6197927B1Mar 6, 2001
Peptide variants of protein A
GENENTECH INC57 citations95
US6136563AOct 24, 2000
Human growth hormone variants comprising amino acid substitutions
GENENTECH INC67 citations95
US6004931ADec 21, 1999
Method for inhibiting growth hormone action
GENENTECH INC85 citations95
US5506107AApr 9, 1996
Selecting ligand agonists and antagonists
GENENTECH INC167 citations95
US6936440B1Aug 30, 2005
Selecting ligand agonists and antagonists
GENENTECH INC25 citations93
US5741664AApr 21, 1998
Subtilisin variants capable of cleaving substrates containing dibasic residues
GENENTECH INC21 citations92
GENENCOR INC
6 patentsUSRE34606EMay 10, 1994
Modified enzymes and methods for making same
GENENCOR INC368 citations99
US4760025AJul 26, 1988
Modified enzymes and methods for making same
GENENCOR INC963 citations99
US5441882AAug 15, 1995
Method for preparing modified subtilisins
GENENCOR INC83 citations96
US5310675AMay 10, 1994
Procaryotic carbonyl hydrolases
GENENCOR INC73 citations96
US5411873AMay 2, 1995
Process for producing heterologous polypeptides
GENENCOR INC60 citations95
US5346823ASep 13, 1994
Subtilisin modifications to enhance oxidative stability
GENENCOR INC52 citations93
GENENCOR INT
4 patentsUS5182204AJan 26, 1993
Non-human carbonyl hydrolase mutants, vectors encoding same and hosts transformed with said vectors
GENENCOR INT75 citations96
US5472855ADec 5, 1995
Substrate assisted catalysis
GENENCOR INT28 citations93
US5371190ADec 6, 1994
Substrate assisted catalysis
GENENCOR INT28 citations93
US5371008ADec 6, 1994
Substrate assisted catalysis
GENENCOR INT26 citations93
TELEDYNE IND
1 patentWELLS JAMES A
1 patentShowing the top 50 of 69 patents by PatentIndex Score.